Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
Sponsor: GenMont Biotech Incorporation
Summary
Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer patients. This study is designed to explore after consumption of probiotics of lactobacillus composite strain powder sachets for 6 months in breast cancer chemotherapy, and whether the improvement of meliorate the side effects, further assists patients completing the chemotherapy.
Official title: To Evaluate the Efficacy of Probiotics in Improvement and Prevention of Chemotherapy Associated Side Effectes in Patients With the Breast Cancer
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-04-08
Completion Date
2026-12-31
Last Updated
2026-03-06
Healthy Volunteers
No
Conditions
Interventions
Probiotic
Three-strain probiotic supplement includes Lactobacillus reuteri GMNL-89 (alive), Lactobacillus plantarum GMNL-141 (alive) and Lactobacillus paracasei GMNL-133 (alive).
Placebo
Same additives to Probiotic group but replace probiotics with corn starch and Maltodextrin.
Locations (1)
Mackay Memorial Hospital
Taipei, Taiwan